133 related articles for article (PubMed ID: 22270992)
1. Early data from the first population-wide breast cancer-specific registry in Hong Kong.
Cheung P; Hung WK; Cheung C; Chan A; Wong TT; Li L; Chan SW; Chan KW; Choi P; Kwan WH; Yau CC; Chan EY; Law SC; Kwan D
World J Surg; 2012 Apr; 36(4):723-9. PubMed ID: 22270992
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
Yau TK; Chan A; Cheung PS
Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.
Kwong A; Mang OW; Wong CH; Chau WW; Law SC;
Ann Surg Oncol; 2011 Oct; 18(11):3072-8. PubMed ID: 21847700
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic disparity in breast cancer detection in Hong Kong--a high income city: retrospective epidemiological study using the Breast Cancer Registry.
Chor JS; Lam HC; Chan A; Lee HM; Fok E; Griffiths S; Cheung P
PLoS One; 2014; 9(10):e107630. PubMed ID: 25271739
[TBL] [Abstract][Full Text] [Related]
5. Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer Registry.
Chan YHY; Kwok CCH; Tse DMS; Lee HM; Tam PY; Cheung PSY
Hong Kong Med J; 2023 Jun; 29(3):198-207. PubMed ID: 37019476
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of patients with ductal carcinoma in situ in Hong Kong: 10-year territory-wide cancer registry study.
Co M; Ngan RKC; Mang OWK; Tam AHP; Wong KH; Kwong A
Hong Kong Med J; 2020 Dec; 26(6):486-491. PubMed ID: 33277445
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
Wong KH; Mang OW; Au KH; Law SC
Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997-2006.
Kwong A; Chau WW; Mang OW; Wong CH; Suen DT; Leung R; Wong K; Lee A; Shea C; Morse E; ; Law SC
Ann Surg Oncol; 2014 Apr; 21(4):1246-53. PubMed ID: 24337541
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a programming effect of early menarche on the rise of breast cancer incidence in Hong Kong.
Leung AW; Mak J; Cheung PS; Epstein RJ
Cancer Detect Prev; 2008; 32(2):156-61. PubMed ID: 18632223
[TBL] [Abstract][Full Text] [Related]
10. Disparities of time trends and birth cohort effects on invasive breast cancer incidence in Shanghai and Hong Kong pre- and post-menopausal women.
Wang F; Tse LA; Chan WC; Kwok CC; Leung SL; Wu C; Mang OW; Ngan RK; Li M; Yu WC; Tsang KH; Law SH; Miao X; Wu C; Zheng Y; Wu F; Yang XR; Yu IT
BMC Cancer; 2017 May; 17(1):362. PubMed ID: 28535760
[TBL] [Abstract][Full Text] [Related]
11. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis.
Leung GM; Thach TQ; Lam TH; Hedley AJ; Foo W; Fielding R; Yip PS; Lau EM; Wong CM
Br J Cancer; 2002 Oct; 87(9):982-8. PubMed ID: 12434289
[TBL] [Abstract][Full Text] [Related]
12. Young onset breast cancer in Southern China - a 5-year clinico-pathological study from a multi-centre database.
Co M; Kwong A
Cancer Treat Res Commun; 2020; 24():100182. PubMed ID: 32534410
[TBL] [Abstract][Full Text] [Related]
13. Major trauma care in Hong Kong and Germany: a trauma registry data benchmark study.
Lai CY; Maegele M; Yeung JHH; Lefering R; Hung KCK; Chan PSL; Leung M; Wong HT; Wong JKS; Graham CA; Cheng CH; Cheung NK
Eur J Trauma Emerg Surg; 2021 Oct; 47(5):1581-1590. PubMed ID: 32128612
[TBL] [Abstract][Full Text] [Related]
14. Long-term Survival Outcomes of 'Low Risk' Ductal Carcinoma in situ from a Territory-wide Cancer Registry.
Co M; Ngan RKC; Mang OWK; Tam AHP; Wong KH; Kwong A
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):40-45. PubMed ID: 32713775
[TBL] [Abstract][Full Text] [Related]
15. Short-term, medium-term, long-term, and lifetime risks of developing and dying of breast carcinoma in a Westernized Chinese population: Evidence from Hong Kong between 1976 and 2000.
Leung GM; Thach TQ; Chan E; Foo W; Meng O; Fielding R; Lam WW; Hedley AJ; Wong CM; Lam TH
Cancer; 2005 Feb; 103(3):501-8. PubMed ID: 15597378
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong.
Cheung PS; Tong AC; Leung RC; Kwan WH; Yau TC
Hong Kong Med J; 2014 Oct; 20(5):401-6. PubMed ID: 24948666
[TBL] [Abstract][Full Text] [Related]
17. HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.
Yau TK; Sze H; Soong IS; Hioe F; Khoo US; Lee AW
Hong Kong Med J; 2008 Apr; 14(2):130-5. PubMed ID: 18382020
[TBL] [Abstract][Full Text] [Related]
18. Differential incidence trends of colon and rectal cancers in Hong Kong: an age-period-cohort analysis.
Zhang B; Xie SH; Yu IT
Cancer Commun (Lond); 2018 Jun; 38(1):42. PubMed ID: 29954444
[TBL] [Abstract][Full Text] [Related]
19. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience.
Lui CY; Lam HS; Chan LK; Tam KF; Chan CM; Leung TY; Mak KL
Hong Kong Med J; 2007 Apr; 13(2):106-13. PubMed ID: 17406037
[TBL] [Abstract][Full Text] [Related]
20. Pediatric stroke among Hong Kong Chinese subjects.
Chung B; Wong V
Pediatrics; 2004 Aug; 114(2):e206-12. PubMed ID: 15286258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
